Chicago Capital’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,362,484
| Closed | -$29.4M | – | 237 |
|
|
2022
Q4 | $29.4M | Buy |
1,362,484
+242,710
| +22% | +$5.24M | 1.63% | 27 |
|
|
2022
Q3 | $21.7M | Sell |
1,119,774
-231,460
| -17% | -$4.48M | 1.25% | 34 |
|
|
2022
Q2 | $26.8M | Buy |
1,351,234
+339,490
| +34% | +$6.74M | 1.48% | 30 |
|
|
2022
Q1 | $30.2M | Buy |
1,011,744
+162,505
| +19% | +$4.85M | 1.3% | 36 |
|
|
2021
Q4 | $19.8M | Buy |
849,239
+29,501
| +4% | +$687K | 0.74% | 44 |
|
|
2021
Q3 | $25.6M | Buy |
819,738
+122,502
| +18% | +$3.82M | 0.97% | 38 |
|
|
2021
Q2 | $24.5M | Buy |
697,236
+10,898
| +2% | +$383K | 0.96% | 40 |
|
|
2021
Q1 | $24.2M | Buy |
686,338
+68,075
| +11% | +$2.4M | 1.02% | 40 |
|
|
2020
Q4 | $23.2M | Buy |
618,263
+107,820
| +21% | +$4.04M | 1.04% | 40 |
|
|
2020
Q3 | $17M | Buy |
510,443
+8,231
| +2% | +$275K | 0.88% | 39 |
|
|
2020
Q2 | $13.3M | Buy |
502,212
+9,334
| +2% | +$247K | 0.77% | 40 |
|
|
2020
Q1 | $8.07M | Buy |
492,878
+317,589
| +181% | +$5.2M | 0.65% | 45 |
|
|
2019
Q4 | $4.46M | Sell |
175,289
-47,260
| -21% | -$1.2M | 0.27% | 59 |
|
|
2019
Q3 | $4.45M | Buy |
222,549
+20,308
| +10% | +$406K | 0.3% | 58 |
|
|
2019
Q2 | $6.52M | Buy |
202,241
+12,833
| +7% | +$414K | 0.42% | 58 |
|
|
2019
Q1 | $6.1M | Buy |
189,408
+8,497
| +5% | +$274K | 0.41% | 57 |
|
|
2018
Q4 | $4.44M | Buy |
180,911
+20,663
| +13% | +$507K | 0.36% | 56 |
|
|
2018
Q3 | $5.28M | Buy |
160,248
+25,500
| +19% | +$841K | 0.37% | 52 |
|
|
2018
Q2 | $4.78M | Buy |
134,748
+43,917
| +48% | +$1.56M | 0.39% | 54 |
|
|
2018
Q1 | $2.96M | Buy |
+90,831
| New | +$2.96M | 0.39% | 52 |
|